Jinarc
What it is used for
JINARC is indicated to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (CKD) stage 1 to 3 at initiation of treatment with evidence of rapidly progressing disease (see PHARMACOLOGY).
How to take it
This medicine is a pack that contains more than one part.
Part 1: Tablet
A blue square shallow-convex tablet debossed with “OTSUKA” and “45” on one side
The way to take this medicine is: Oral. This medicine is taken by mouth.
Part 2: Tablet
A blue triangular shallow-convex tablet debossed with “otsuka” and “15” on one side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
This medicine is a pack that contains more than one part.
Part 1: Tablet
A blue square shallow-convex tablet debossed with “OTSUKA” and “45” on one side
The way to take this medicine is: Oral. This medicine is taken by mouth.
Part 2: Tablet
A blue triangular shallow-convex tablet debossed with “otsuka” and “15” on one side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Pregnant or planning a pregnancy?
For the active ingredient tolvaptan
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Visual appearance
A blue triangular shallow-convex tablet debossed with “OTSUKA” and “15” on one side.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.